Lumiradx Uk Limited

This study tested a quick COVID-19 antigen test called LumiraDx at various point-of-care sites, like clinics. Over 1,100 people with COVID-19 symptoms took part. The test's accuracy was compared to standard lab methods to see how well it detects the virus.

This study tested whether a fingerstick blood test (LumiraDx INR test) gives accurate results for people taking the blood thinner phenprocoumon. Researchers compared fingerstick results to standard lab tests in 102 adults. The goal is to see if this quick test can reliably monito…

This study tested a new rapid test (LumiraDx Influenza A/B + RSV Test) that uses a nasal swab to quickly detect flu A, flu B, and RSV. Over 500 people with cold or flu-like symptoms took part. The test was performed by healthcare workers at point-of-care sites and compared to sta…

This study tested how well a small, portable device (LumiraDx) measures blood clotting (INR) compared to standard lab tests. Researchers collected blood from 420 adults, some taking warfarin and some not, using both a fingerstick and a vein draw. The goal was to see if the device…

This study tested a new point-of-care device that measures HbA1c (a key blood sugar marker) from a finger-prick sample. Researchers compared its results to a standard lab method in 177 adults with or at risk for diabetes. The goal was to see if the quick test is accurate enough f…

This study tested two new rapid swab tests that can detect COVID-19, influenza A/B, and RSV from a single sample. Researchers enrolled 589 people with symptoms and compared the test results to standard lab methods. The goal was to see how accurate and easy the tests are to use at…

This study checked how accurate two rapid tests (LumiraDx SARS-CoV-2 Ag Ultra and LumiraDx SARS-CoV-2 & Flu A/B) are at detecting COVID-19 and flu in people with symptoms. 716 participants provided nasal swabs at clinics. The results were compared to standard lab tests to measure…

This study checked if a new, fast blood test (LumiraDx D-Dimer) can accurately help diagnose dangerous blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism). Researchers compared the new test to a standard lab test in 679 adults with symptoms. The goal was …

This study collected nose, throat, and blood samples from 523 adults with COVID-19 symptoms or a past positive test. The goal was to help develop and check the accuracy of a new rapid test for detecting COVID-19 antibodies and viral proteins. The test is designed to be used at th…

This study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…

This study collected nose and throat swabs from 79 people with symptoms of flu, RSV, or COVID-19. The samples were used to help evaluate a rapid point-of-care test. The goal was to see how well the device detects these viruses in different people.